0000950172-15-000087.txt : 20150914 0000950172-15-000087.hdr.sgml : 20150914 20150914123429 ACCESSION NUMBER: 0000950172-15-000087 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20150914 DATE AS OF CHANGE: 20150914 EFFECTIVENESS DATE: 20150914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Strongbridge Biopharma plc CENTRAL INDEX KEY: 0001634432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981130690 STATE OF INCORPORATION: L2 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-247545 FILM NUMBER: 151105087 BUSINESS ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: (610) 254-9200 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 FORMER COMPANY: FORMER CONFORMED NAME: Cortendo AB DATE OF NAME CHANGE: 20150219 D 1 primary_doc.xml X0707 D LIVE 0001634432 Strongbridge Biopharma plc 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA PENNSYLVANIA 19053 (610) 254-9200 IRELAND Cortendo AB Other Irish public limited company true 2015 Matthew Pauls 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Executive Officer Director Ruth Thieroff-Ekerdt 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Executive Officer Robert Lutz 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Executive Officer Stephen Long 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Executive Officer A. Brian Davis 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Executive Officer Hilde H. Steineger 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Director Richard Kollender 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Director Marten Steen 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Director John H. Johnson 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Director Garheng Kong 900 Northbrook Drive Suite 200 Trevose PA PENNSYLVANIA 19053 Director Pharmaceuticals No Revenues 06c false 2015-08-28 false true true The offering was made in connection with the redomiciliation of the parent of the Cortendo group from Sweden to Ireland, which was effected via an exchange offer by the issuer for all issued and outstanding shares of Cortendo AB (publ). 0 126000000 126000000 0 Based on closing price of Cortendo AB shares (in USD) on the expiration of the exchange offer false 46 0 0 0 No securities were offered for cash in the exchange offer and therefore the issuer did not receive any proceeds in respect of the offering. false Strongbridge Biopharma plc /s/ Brian Davis Brian Davis Chief Financial Officer 2015-09-14